For patients with osteoarthritis, the goal is to prevent joint replacement surgery for as long as possible because the artificial joint typically only lasts around 20 years before a very complex revision surgery is needed.
So doctors try for a temporary solution, which involves injecting a viscous fluid into your joint. The problem is that the typical injection only lasts for a few weeks.
Now, a Boston University post-doctoral fellow has developed a new fluid called ABX Viscoelastic that is projected to provide osteoarthritis patients six months of relief, and potentially even up to one year. His company Articulate Biosciences uses tissue-protecting and function-restoring biomedical polymers that are biocompatible and provide cushioning and lubrication to the joints.